Thomson X, a subsidiary of SGX-listed Thomson Medical Group, has inked a strategic partnership with eye healthtech startup Plano.
In a statement, the two organisations said that the collaboration will leverage on the respective strengths of TX and Plano to address and manage the rapidly increasing incidence of myopia through innovative technological solutions.
Thomson X, a platform that is focused on simplifying healthcare through technology, oversees Thomson Medical Group’s technology roadmap by connecting healthtech startups with its healthcare expertise and network to scale up rapidly and maximise their reach. Through the partnership, the Group’s patients at Thomson Paediatric Clinic and Thomson Kids in Singapore, and Thomson Eye Centre in Malaysia will soon have access to Plano’s eyecare solutions on top of Thomson’s existing healthcare services.
In addition, the partnership will also accelerate Plano’s market potential through TX’s global partner, the Global Esports Federation, by delivering eye health services to esports athletes and gamers who are exposed to long screen time.
The partnership will also grant TX an option to subscribe for an equity stake in Plano which can be exercised in three tranches over a six-year period based on certain conditions. If all three tranches are exercised, TX will hold a minority stake in Plano
Founded in 2017 by Mohamed Dirani, Plano is the first spin-off from the Singapore Eye Research Institute (SERI) – Singapore National Eye Centre (SNEC) Ophthalmic Technologies Incubator Programme, dedicated to accelerating ophthalmic R&D projects towards commercialisation and medical deployment.
The company’s key products are an application and an online optometry booking system, Plano Eyecheck.
The company says that in only three years the application has been adopted by more than 250,000 households.